|
CDKN2AIPNL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.851000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.308400E-01 |
| Normal-vs-Stage2 |
8.664200E-01 |
| Normal-vs-Stage3 |
5.702600E-01 |
| Normal-vs-Stage4 |
6.695200E-01 |
| Stage1-vs-Stage2 |
8.687000E-01 |
| Stage1-vs-Stage3 |
8.528400E-01 |
| Stage1-vs-Stage4 |
3.764800E-01 |
| Stage2-vs-Stage3 |
7.825400E-01 |
| Stage2-vs-Stage4 |
6.235000E-01 |
| Stage3-vs-Stage4 |
3.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.909000E-01 |
| Normal-vs-AfricanAmerican |
7.895200E-03 |
| Normal-vs-Asian |
1.842580E-01 |
| Caucasian-vs-AfricanAmerican |
2.985000E-03 |
| Caucasian-vs-Asian |
7.639600E-02 |
| AfricanAmerican-vs-Asian |
9.445000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.912800E-01 |
| Normal-vs-Female |
3.247600E-01 |
| Male-vs-Female |
2.441200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.027600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.863800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.172200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.006200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.239600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.228610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.855100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.904400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.727700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.511800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.458040E-01 |
| Normal-vs-Grade 2 |
9.798200E-01 |
| Normal-vs-Grade 3 |
8.523000E-01 |
| Normal-vs-Grade 4 |
4.515400E-01 |
| Grade 1-vs-Grade 2 |
8.660300E-02 |
| Grade 1-vs-Grade 3 |
1.131770E-01 |
| Grade 1-vs-Grade 4 |
3.720800E-01 |
| Grade 2-vs-Grade 3 |
8.491400E-01 |
| Grade 2-vs-Grade 4 |
4.291400E-01 |
| Grade 3-vs-Grade 4 |
5.029400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.976980E-01 |
| Normal-vs-ccB subtype |
1.155590E-02 |
| ccA subtype-vs-ccB subtype |
2.49559999999649E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.529200E-01 |
| Normal-vs-N1 |
4.732800E-01 |
| N0-vs-N1 |
2.508400E-01 |
|
|
